16th Jun 2015 08:19
UK stocks dropped into the red for a third straight day on Tuesday on the back of ongoing concerns about Greece, a sell-off in China and caution ahead of inflation data. The FTSE 100 was trading 0.55% lower at 6,673.49 early on, after hitting a three-month closing low of 6,710.52 on Monday. The ind
Read more11th Jun 2015 07:03
President Obama's election pledge not to drag the US into another war in Iraq was last night under increasing strain as he sent a further 450 soldiers to Anbar province to confront Isis. The move, which brings to about 3,550 the number of US troops in Iraq, underscores alarm at how the Iraqi army cr
Read more3rd Jun 2015 07:29
The UK markets regulator has given his backing to asset managers fighting proposals that could see them labelled as potential threats to the financial system. Martin Wheatley, head of Britain's Financial Conduct Authority, said global regulators faced "big questions" that needed to be answered befor
Read more1st Jun 2015 13:49
UK shares were trading lower on Monday afternoon, ahead of a raft of US economic data, as weakness in mining, oil and insurance stocks outweighed gains made in the real estate, travel and electronics sectors. As of 15:30 BST, the FTSE 100 was trading 0.23% lower at 6,988. Lloyds registered losses a
Read more1st Jun 2015 09:48
Lamprell: Citi reiterates neutral recommendation and raises target to 155p. British Land: JP Morgan ups target to 970p from 950p and stays at overweight. Derwent London: JP Morgan raises target to 3,900p from 3,800p but keeps at overweight. Great Portland Estates: JP Morgan lifts target to 920p fr
Read more1st Jun 2015 08:24
Stocks pared strong early gains ahead of a raft of US economic data scheduled for release in the afternoon amid continued worries over the situation in Greece. As of 08:56 the FTSE 100 was higher by 24.21 points to 7,008.64. The top flight index snapped higher at the start of the session following
Read more1st Jun 2015 07:35
Shares in AstraZeneca rose 2.5% on Monday following positive takeaways from the annual meeting of the American Society of Clinical Oncology, during which the company presented preliminary data for one of its lung cancer drugs. The pharmaceuticals giant announced preliminary efficacy and safety data
Read more1st Jun 2015 07:16
Clinical data unveiled on Sunday on occasion of the American Society of Clinical Oncology's annual conference in Chicago showed that a combination of two immunotherapy drugs made by global biopharmaceutical Bristol-Myers Squibb could rise the chances of surviving skin cancer. This combination was fo
Read more29th May 2015 17:42
Shares ended the week on a down note, as worries over Greece continued to weigh on investors' minds. Even so, speaking after the close of markets the Mediterranean country's economics minister, Giorgios Stathakis, said Athens will be able to repay the first tranche of its loans to the IMF on 5 June.
Read more29th May 2015 14:40
UK drug colossus Astrazeneca and US peer Eli Lilly have agreed to collaborate on the hot area of immuno-oncology, where drugs encourage the body's immune system to help battle cancer. The FTSE 100 group, which last month agreed a major collaboration with Celgene, will combine one of its experimental
Read more29th May 2015 12:44
UK stocks shook off early morning caution by the afternoon, making modest gains in spite of Greek debt and panic selling on Chinese markets. As of 14:00 BST, the FTSE 100 was trading 0.04% higher at 7,044. Weir topped the risers as Credit Suisse raised its price target on the stock to 2,205p, citin
Read more27th May 2015 07:57
Beazley: JP Morgan upgrades to overweight from neutral and sets 308p target, up from 255p. Hiscox: JP Morgan upgrades to overweight from neutral and ups target to 950p from 801p. Lancashire Holdings: JP Morgan improves target price to 642p from 589p, stays at neutral. Dixons Carphone: Exane keeps
Read more26th May 2015 13:18
UK stocks were were buffeted on Tuesday by Greek uncertainty, stateside interest rate speculation and weakness among miners and financials. As of 14:30 BST, the FTSE 100 was trading 23.5 points lower at 7,008.24. Banking stocks with high eurozone exposure plummeted as Greece concerns merged with Sp
Read more26th May 2015 09:54
Shares in drugmaker AstraZeneca fell 1.2%, as investors reacted to news that one of its partners, Amgen, was ending its collaboration to develop psoriasis drug brodalumab, after suicidal thoughts were observed in patients taking it. Amgen and AstraZeneca had been sharing development of the drug sinc
Read more18th May 2015 10:07
Biopharmaceutical giant AstraZeneca has announced it will invest £182m to expand biotech drug manufacturing in Sweden. In a statement released on Monday, the FTSE 100 group said the new facility will be used to supply medicines for clinical trial programmes from the end of 2018, with delivery of fin
Read more